GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 791 filers reported holding GLAXOSMITHKLINE PLC in Q2 2021. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $490,000 | 0.0% | 11,250 | 0.0% | 0.15% | +18.5% |
| Q1 2022 | $490,000 | +3.4% | 11,250 | +4.7% | 0.13% | +11.1% |
| Q4 2021 | $474,000 | +15.3% | 10,750 | 0.0% | 0.12% | +3.5% |
| Q3 2021 | $411,000 | +94.8% | 10,750 | +102.8% | 0.11% | +76.6% |
| Q2 2021 | $211,000 | +157.3% | 5,300 | +130.4% | 0.06% | +146.2% |
| Q1 2021 | $82,000 | -3.5% | 2,300 | 0.0% | 0.03% | -7.1% |
| Q4 2020 | $85,000 | -2.3% | 2,300 | 0.0% | 0.03% | -9.7% |
| Q3 2020 | $87,000 | -7.4% | 2,300 | 0.0% | 0.03% | -13.9% |
| Q2 2020 | $94,000 | +8.0% | 2,300 | 0.0% | 0.04% | -7.7% |
| Q1 2020 | $87,000 | -19.4% | 2,300 | 0.0% | 0.04% | 0.0% |
| Q4 2019 | $108,000 | +10.2% | 2,300 | 0.0% | 0.04% | +5.4% |
| Q3 2019 | $98,000 | +716.7% | 2,300 | +666.7% | 0.04% | +640.0% |
| Q2 2019 | $12,000 | -7.7% | 300 | 0.0% | 0.01% | 0.0% |
| Q1 2019 | $13,000 | +18.2% | 300 | 0.0% | 0.01% | 0.0% |
| Q4 2018 | $11,000 | -8.3% | 300 | 0.0% | 0.01% | 0.0% |
| Q3 2018 | $12,000 | 0.0% | 300 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $12,000 | 0.0% | 300 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $12,000 | +9.1% | 300 | 0.0% | 0.01% | +25.0% |
| Q4 2017 | $11,000 | -8.3% | 300 | 0.0% | 0.00% | -20.0% |
| Q3 2017 | $12,000 | -7.7% | 300 | 0.0% | 0.01% | 0.0% |
| Q2 2017 | $13,000 | 0.0% | 300 | 0.0% | 0.01% | -16.7% |
| Q1 2017 | $13,000 | -66.7% | 300 | -70.0% | 0.01% | -66.7% |
| Q4 2016 | $39,000 | -9.3% | 1,000 | 0.0% | 0.02% | -10.0% |
| Q3 2016 | $43,000 | 0.0% | 1,000 | 0.0% | 0.02% | 0.0% |
| Q2 2016 | $43,000 | +53.6% | 1,000 | +42.9% | 0.02% | +42.9% |
| Q1 2016 | $28,000 | 0.0% | 700 | 0.0% | 0.01% | +7.7% |
| Q4 2015 | $28,000 | +3.7% | 700 | 0.0% | 0.01% | -7.1% |
| Q3 2015 | $27,000 | -91.9% | 700 | -91.3% | 0.01% | -90.7% |
| Q2 2015 | $334,000 | -9.7% | 8,025 | 0.0% | 0.15% | -7.4% |
| Q1 2015 | $370,000 | +0.3% | 8,025 | -7.0% | 0.16% | -0.6% |
| Q4 2014 | $369,000 | – | 8,625 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
| Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
| Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
| Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
| P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
| Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
| Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
| Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
| Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
| JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |